The P3 Event-Related Potential is a Biomarker for the Efficacy of Vagus Nerve Stimulation in Patients with Epilepsy
- 434 Downloads
Currently, the mechanism of action of vagus nerve stimulation (VNS) is not fully understood, and it is unclear which factors determine a patient’s response to treatment. Recent preclinical experiments indicate that activation of the locus coeruleus noradrenergic system is critical for the antiepileptic effect of VNS. This study aims to evaluate the effect of VNS on noradrenergic signaling in the human brain through a noninvasive marker of locus coeruleus noradrenergic activity: the P3 component of the event-related potential. We investigated whether VNS differentially modulates the P3 component in VNS responders versus VNS nonresponders. For this purpose, we recruited 20 patients with refractory epilepsy who had been treated with VNS for at least 18 months. Patients were divided into 2 groups with regard to their reduction in mean monthly seizure frequency: 10 responders (>50 %) and 10 nonresponders (≤50 %). Two stimulation conditions were compared: VNS OFF and VNS ON. In each condition, the P3 component was measured during an auditory oddball paradigm. VNS induced a significant increase of the P3 amplitude at the parietal midline electrode, in VNS responders only. In addition, logistic regression analysis showed that the increase of P3 amplitude can be used as a noninvasive indicator for VNS responders. These results support the hypothesis that activation of the locus coeruleus noradrenergic system is associated with the antiepileptic effect of VNS. Modulation of the P3 amplitude should be further investigated as a noninvasive biomarker for the therapeutic efficacy of VNS in patients with refractory epilepsy.
KeywordsVagus nerve stimulation epilepsy event-related potentials P3 biomarker norepinephrine.
L. De Taeye is supported by a Fonds Wetenschappelijk Onderzoek (FWO) aspirant grant. K. Vonck is supported by a Bijzonder Onderzoeksfonds (BOF) grant from Ghent University Hospital. P. Boon is supported by grants from FWO, grants from BOF, and by the Clinical Epilepsy Grant from Ghent University Hospital. M. van Bochove, L. Mollet, and T. Verguts are supported by grants from FWO. R. Raedt is supported by a BOF Tenure Track grant from Ghent University.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
- 5.Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2002:CD002896.Google Scholar
- 25.Luck SJ. An introduction to the event-related potential technique. MIT Press, Harvard, MA, 2005.Google Scholar
- 41.Kanner A, Schachter SC. Psychiatric controversies in epilepsy. Elsevier Science, Academic Press, Amsterdam, The Netherlands, 2010.Google Scholar
- 53.Sackeim HA, Keilp JG, Rush AJ, et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behave Neurol 2001;14:53–62.Google Scholar